Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products focusing on cardiovascular and cerebrovascular medication, respiratory infections, and pediatric diseases. In addition, the company trades agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Frequently asked questions
What sector does Tianda Pharmaceuticals Ltd (0455) operate in?
Tianda Pharmaceuticals Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Tianda Pharmaceuticals Ltd (0455) current stock price?
As of the latest data, Tianda Pharmaceuticals Ltd stock price is HK$0.11, with a previous close of HK$0.11. Tianda Pharmaceuticals Ltd gained HK$0.00 in the last trading session, representing a 0.92% increase.
What is Tianda Pharmaceuticals Ltd (0455) current market capitalization?
Tianda Pharmaceuticals Ltd market cap is approximately 236.50 million.
Does Tianda Pharmaceuticals Ltd (0455) pay dividends?
No. Tianda Pharmaceuticals Ltd does not pay a dividend.
What is Tianda Pharmaceuticals Ltd (0455) beta (volatility) score?
Tianda Pharmaceuticals Ltd has a beta of -0.056, indicating lower volatility than the overall market.
